搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Medscape
4 小时
Fibrosis Risk High in Young Adults With Both Obesity and T2D
Both obesity and type 2 diabetes can override the potential protective effect of young age on liver health, leaving this ...
Daily
9 小时
Study Identifies Key Factors Predicting Liver Fibrosis Progression in Type 2 Diabetes with ...
As liver fibrosis can lead to cirrhosis and increase the risk of liver-related complications, understanding factors that ...
1 天
on MSN
‘I had no idea being a social drinker would damage my liver by 31’
I was shocked because I didn’t drink every day, I never drank alone and I drank because I enjoyed it as a social activity, ...
News Medical on MSN
17 天
Exploring mouse models for studying liver fibrosis regression
Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be ...
The American Journal of Managed Care
13 天
Liver Steatosis, Fibrosis Highly Prevalent in People Living With HIV
The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...
The American Journal of Managed Care
12 天
Liver Fibrosis Scores May Hint at Heart Failure Risk
Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing ...
Medpage Today on MSN
5 天
Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH
Patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis who received a novel ...
infectiousdiseaseadvisor.com
17 小时
Liver Disease Progression Seen After Curative DAA Therapy in HIV, HCV Coinfection
Hepatic steatosis steadily increased in patients with HIV and HCV coinfection despite curative treatment with DAA therapy.
FierceBiotech
5 天
Viking pads case for MASH drug with final ph. 2 data showing significant reductions in ...
Patients in the treatment arms received 1 mg, 2.5 mg, 5 mg or 10 mg doses. After 52 weeks of treatment, patients taking the ...
eLife
12 天
Dynamics of compartment-specific proteomic landscapes of hepatotoxic and cholestatic models ...
Accumulation of extracellular matrix (ECM) in liver fibrosis is associated with changes in protein abundance and composition depending upon etiology of the underlying liver disease. Current efforts to ...
8 天
Carisma Reports Promising Preclinical Data On Engineered Macrophages For Liver Fibrosis
Carisma Therapeutics Inc. (CARM) presented promising preclinical data on engineered macrophages for treating liver fibrosis at the ...
10 天
Akero Therapeutics to Showcase New Analyses of Phase 2b HARMONY Study in Presentations at ...
Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver fibrosis by all of three ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈